ATE349427T1 - Tryptaseinhibitoren - Google Patents
TryptaseinhibitorenInfo
- Publication number
- ATE349427T1 ATE349427T1 AT02722097T AT02722097T ATE349427T1 AT E349427 T1 ATE349427 T1 AT E349427T1 AT 02722097 T AT02722097 T AT 02722097T AT 02722097 T AT02722097 T AT 02722097T AT E349427 T1 ATE349427 T1 AT E349427T1
- Authority
- AT
- Austria
- Prior art keywords
- tryptase inhibitors
- inhibitors
- compounds
- formula
- tryptase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Luminescent Compositions (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01104109 | 2001-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE349427T1 true ATE349427T1 (de) | 2007-01-15 |
Family
ID=8176550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02722097T ATE349427T1 (de) | 2001-02-21 | 2002-02-19 | Tryptaseinhibitoren |
Country Status (9)
Country | Link |
---|---|
US (1) | US7060716B2 (de) |
EP (1) | EP1368317B1 (de) |
JP (1) | JP2004518736A (de) |
AT (1) | ATE349427T1 (de) |
AU (1) | AU2002253035B8 (de) |
CA (1) | CA2438685A1 (de) |
DE (1) | DE60217076T2 (de) |
ES (1) | ES2278913T3 (de) |
WO (1) | WO2002066430A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102771A1 (en) | 2001-06-19 | 2002-12-27 | Altana Pharma Ag | Tryptase inhibitors |
CN105209435B (zh) * | 2013-05-14 | 2018-02-02 | 3M创新有限公司 | 包含吡啶或吡嗪的化合物 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995032945A1 (en) | 1994-06-01 | 1995-12-07 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
WO1996009297A1 (en) | 1994-09-23 | 1996-03-28 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell inflammatory condition |
HUP0003267A3 (en) | 1996-07-30 | 2002-02-28 | Arris Pharmaceutical Corp San | Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them |
AU8997498A (en) | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
EP1030844A1 (de) | 1997-11-10 | 2000-08-30 | Array Biopharma Inc. | Verbindungen, die die aktivität von tryptase hemmen |
US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
ATE282607T1 (de) | 1998-02-06 | 2004-12-15 | Max Planck Gesellschaft | Tryptase-inhibitoren |
JP2002502845A (ja) | 1998-02-06 | 2002-01-29 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | トリプターゼ阻害物質 |
DE19851299A1 (de) * | 1998-02-06 | 1999-08-12 | Max Planck Gesellschaft | Tryptase-Inhibitoren |
WO2000014097A2 (de) | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyranosen |
DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
SI1208089T1 (en) | 1999-08-10 | 2005-04-30 | Altana Pharma Ag | Diazocin-dione derivatives and their use as tryptase inhibitors |
WO2001019809A1 (en) | 1999-09-14 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
CA2392121A1 (en) | 1999-12-20 | 2001-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
CA2392127A1 (en) | 1999-12-20 | 2001-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
-
2002
- 2002-02-19 EP EP02722097A patent/EP1368317B1/de not_active Expired - Lifetime
- 2002-02-19 AT AT02722097T patent/ATE349427T1/de not_active IP Right Cessation
- 2002-02-19 WO PCT/EP2002/001723 patent/WO2002066430A1/en active IP Right Grant
- 2002-02-19 US US10/468,216 patent/US7060716B2/en not_active Expired - Fee Related
- 2002-02-19 ES ES02722097T patent/ES2278913T3/es not_active Expired - Lifetime
- 2002-02-19 JP JP2002565947A patent/JP2004518736A/ja active Pending
- 2002-02-19 DE DE60217076T patent/DE60217076T2/de not_active Expired - Fee Related
- 2002-02-19 CA CA002438685A patent/CA2438685A1/en not_active Abandoned
- 2002-02-19 AU AU2002253035A patent/AU2002253035B8/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US7060716B2 (en) | 2006-06-13 |
EP1368317B1 (de) | 2006-12-27 |
DE60217076T2 (de) | 2007-06-21 |
AU2002253035B8 (en) | 2008-02-21 |
CA2438685A1 (en) | 2002-08-29 |
DE60217076D1 (en) | 2007-02-08 |
AU2002253035B2 (en) | 2007-08-23 |
ES2278913T3 (es) | 2007-08-16 |
US20040067943A1 (en) | 2004-04-08 |
WO2002066430A1 (en) | 2002-08-29 |
JP2004518736A (ja) | 2004-06-24 |
EP1368317A1 (de) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04002067A (es) | Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento. | |
ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
NO20034660D0 (no) | Spiropyrazolforbindelser | |
BR0111451A (pt) | Inibidores de serina protease | |
NO20041493L (no) | Kjemiske forbindelser. | |
SE0100903D0 (sv) | Compounds | |
ATE552834T1 (de) | Zubereitung von 1,6-disubstituierten azabenzimidazolen als kinasehemmer | |
ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
SE0004245D0 (sv) | Novel compounds and their use | |
ATE275544T1 (de) | Serinprotease-inhibitoren | |
DE50202504D1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
SE0103710D0 (sv) | Compounds | |
ATE287403T1 (de) | 6-phenylbenzonaphthyidine | |
DK1204659T3 (da) | Serotonerge benzofuraner | |
DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
ATE269313T1 (de) | Tryptase-inhibitoren | |
ATE349427T1 (de) | Tryptaseinhibitoren | |
DK1244614T3 (da) | Tryptase-inhibitorer | |
ATE343390T1 (de) | Kalzilytische verbindungen | |
DE60043228D1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
ATE364037T1 (de) | Tryptasehemmer | |
ATE348803T1 (de) | Tryptase-inhibitoren | |
DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
DK1358182T3 (da) | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |